The Effect of Developing Psychological Resilience on Functionality in Schizophrenia Patients

Sponsor
Sisli Hamidiye Etfal Training and Research Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05739344
Collaborator
Uskudar University (Other)
18
1
1
12
1.5

Study Details

Study Description

Brief Summary

People with schizophrenia have low functionality and psychological resilience. Psychological resilience of individuals can be improved. The funcionality of individual with improved psychological resilience can also be improved. Therefore, both resilience and functionality can be increased by appliying resilience programs to patients with schizophrenia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavioral approach based resilience development program for schizophrenic individuals
N/A

Detailed Description

The aim of study is to determine the effect of the resilience development program applied to schizophrenia patients on the resilience and functionality of the patients. Experimental research design with pretest posttest control group will be used in the study. 36 patients receiving service from a community mental health center will be included in the study (determined by "power analysis"). 18 people will be included in the experimental group and 18 people in the control group (Random appointment will be made by drawing lots). The data of the study will bu collected with "Personal Information Form", "Adult Resilience Scale", "Short Functionality Assessment Scale" and "Beck Cognitive Insight Scale - for Schizophrenic Patients". Consent will be obtained from the individuals participating in the study before the study. An "ethics commitee approval certificate" will also be obtained before starting the study. "Resilience Development Program" based on cognitive behavioral approach developed by the researcher will be applied to the experimental group. SPSS 28.0 program will be used in the analysis of the data. Mean, standard deviation, median, minimum and maximum values will be used in the descriptive statistics of the data. Mann whitney u test, chi-square test and wilcoxon test will be used in the analysis of quantitative independent data.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
18 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of the Cognitive Behavioral Therapy - Based Resilience Development Program Applied to Schizophrenia Patients on Resilience and Functionality
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

Cognitive behavioral approach based resilience development program

Behavioral: Cognitive behavioral approach based resilience development program for schizophrenic individuals
The intervention will be administered as sessions of 2 hours once a week.

Outcome Measures

Primary Outcome Measures

  1. Resilience level [After 12 weeks]

    High resilience score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be at least literate

  • Be in remision

  • Not have mental retardation, hearing and speech problem

Exclusion Criteria:
  • Those in acute exacerbation

  • Those with other psychiatric illnesses

  • Those who are / have attended a similar training program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nisantası Community Mental Health Center Istanbul Turkey 34365

Sponsors and Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital
  • Uskudar University

Investigators

  • Principal Investigator: Begum Dag, Sisli Etfal Training and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Begüm Dag, Psychiatric Nurse, Sisli Hamidiye Etfal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05739344
Other Study ID Numbers:
  • Begüm Dağ
First Posted:
Feb 22, 2023
Last Update Posted:
Feb 22, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Begüm Dag, Psychiatric Nurse, Sisli Hamidiye Etfal Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 22, 2023